Raul Delapena Setiawan

Advancing MBC Research Together: From Grant Applications to Clinical Trials

• Patient Advocacy and Support

Advancing MBC Research Together: From Grant Applications to Clinical Trials

Raul Delapena Setiawan June 21, 2026

NASHVILLE, TN — As the landscape of oncology shifts toward more personalized and aggressive interventions for late-stage...

Read More Read more about Advancing MBC Research Together: From Grant Applications to Clinical Trials

A Call for Peace and Resilience: WHO Director-General Dr. Tedros Addresses the Ituri Ebola Crisis

• Breast Cancer Prevention and Lifestyle

A Call for Peace and Resilience: WHO Director-General Dr. Tedros Addresses the Ituri Ebola Crisis

Raul Delapena Setiawan June 21, 2026

By Global Health Correspondent In a deeply personal and urgent appeal, Dr. Tedros Adhanom Ghebreyesus, Director-General of...

Read More Read more about A Call for Peace and Resilience: WHO Director-General Dr. Tedros Addresses the Ituri Ebola Crisis

Bridging the Gap: METAvivor Leadership Drives National Dialogue on Metastatic Breast Cancer Research and Advocacy

• Patient Advocacy and Support

Bridging the Gap: METAvivor Leadership Drives National Dialogue on Metastatic Breast Cancer Research and Advocacy

Raul Delapena Setiawan June 21, 2026

PHILADELPHIA / SAN FRANCISCO — In a whirlwind week that spanned the American continent, leadership from METAvivor,...

Read More Read more about Bridging the Gap: METAvivor Leadership Drives National Dialogue on Metastatic Breast Cancer Research and Advocacy

Beyond Weight Loss: Boehringer Ingelheim Pivots to the Liver as the Next Frontier for Survodutide

• Treatment Innovations

Beyond Weight Loss: Boehringer Ingelheim Pivots to the Liver as the Next Frontier for Survodutide

Raul Delapena Setiawan June 20, 2026

For decades, metabolic dysfunction-associated steatohepatitis (MASH)—formerly known as NASH—was regarded as the "graveyard of drug discovery." The...

Read More Read more about Beyond Weight Loss: Boehringer Ingelheim Pivots to the Liver as the Next Frontier for Survodutide

From Anesthetic to Antidepressant: The Evolution of Spravato and the Pursuit of Remission in TRD

• Treatment Innovations

From Anesthetic to Antidepressant: The Evolution of Spravato and the Pursuit of Remission in TRD

Raul Delapena Setiawan June 20, 2026

More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis during a search for a...

Read More Read more about From Anesthetic to Antidepressant: The Evolution of Spravato and the Pursuit of Remission in TRD

AI and Human Radiologists: A Collaborative Revolution in Breast Cancer Screening Unveiled

• Medical Research and Clinical Trials

AI and Human Radiologists: A Collaborative Revolution in Breast Cancer Screening Unveiled

Raul Delapena Setiawan June 18, 2026

URBANA-CHAMPAIGN, IL – The future of breast cancer screening is not a binary choice between human expertise...

Read More Read more about AI and Human Radiologists: A Collaborative Revolution in Breast Cancer Screening Unveiled

Frontiers in Precision Oncology: The Rise of TCR-Modified Therapies for Pancreatic Cancer

• Clinical Oncology Education

Frontiers in Precision Oncology: The Rise of TCR-Modified Therapies for Pancreatic Cancer

Raul Delapena Setiawan June 17, 2026

The landscape of oncology is currently undergoing a seismic shift. For decades, pancreatic ductal adenocarcinoma (PDAC) has...

Read More Read more about Frontiers in Precision Oncology: The Rise of TCR-Modified Therapies for Pancreatic Cancer

Clinical Uncertainty Clouds Edgewise Therapeutics’ Latest Heart Drug Data

• Chemotherapy and Targeted Therapy

Clinical Uncertainty Clouds Edgewise Therapeutics’ Latest Heart Drug Data

Raul Delapena Setiawan June 17, 2026

By Jonathan Gardner Published June 16, 2026 The cardiovascular therapeutic landscape remains in a state of high-stakes...

Read More Read more about Clinical Uncertainty Clouds Edgewise Therapeutics’ Latest Heart Drug Data

The Great Reining In: How the 2025 Reconciliation Law is Reshaping Medicaid Reimbursement

• Breast Cancer Legislation and Policy

The Great Reining In: How the 2025 Reconciliation Law is Reshaping Medicaid Reimbursement

Raul Delapena Setiawan June 15, 2026

The landscape of American healthcare finance is undergoing a seismic shift. Under the provisions of the 2025...

Read More Read more about The Great Reining In: How the 2025 Reconciliation Law is Reshaping Medicaid Reimbursement

The Island That Said “Yes”: How Tenerife Became a Global Beacon of Solidarity

• Breast Cancer Prevention and Lifestyle

The Island That Said “Yes”: How Tenerife Became a Global Beacon of Solidarity

Raul Delapena Setiawan June 15, 2026

Introduction: A Triumph of Compassion Over Crisis In an era increasingly defined by geopolitical borders, restrictive policies,...

Read More Read more about The Island That Said “Yes”: How Tenerife Became a Global Beacon of Solidarity